Calithera Biosciences Inc - ESG Rating & Company Profile powered by AI
Other corporations in the scoring peer group for Calithera Biosciences Inc are displayed. Scroll down to the end of this webpage for potential risks for Calithera Biosciences Inc based on industry, location and size. This Disclosure rating covers seventeen United Nations SDGs including: 'No Poverty', 'Climate Action' and 'Life below Water'.
Calithera Biosciences Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 3.3; made up of an environmental score of 2.7, social score of 3.2 and governance score of 4.0.
3.3
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1234 | Quanterix Corp | 3.4 | Medium |
| 1234 | X4 Pharmaceuticals Inc | 3.4 | Medium |
| 1253 | Calithera Biosciences Inc | 3.3 | Medium |
| 1253 | Cara Therapeutics Inc | 3.3 | Medium |
| 1253 | Celcuity Inc | 3.3 | Medium |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Calithera Biosciences Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Calithera Biosciences Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Calithera Biosciences Inc report the average age of the workforce?
Sign up for free to unlockDoes Calithera Biosciences Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Calithera Biosciences Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Calithera Biosciences Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Calithera Biosciences Inc offer flexible work?
Sign up for free to unlockDoes Calithera Biosciences Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Calithera Biosciences Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Calithera Biosciences Inc conduct supply chain audits?
Sign up for free to unlockDoes Calithera Biosciences Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Calithera Biosciences Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Calithera Biosciences Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Calithera Biosciences Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Calithera Biosciences Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Calithera Biosciences Inc disclose water use targets?
Sign up for free to unlockDoes Calithera Biosciences Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Calithera Biosciences Inc have a product recall in the last two years?
Sign up for free to unlockDoes Calithera Biosciences Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Calithera Biosciences Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Calithera Biosciences Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Calithera Biosciences Inc disclose parental leave metrics?
Sign up for free to unlockDoes Calithera Biosciences Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Calithera Biosciences Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Calithera Biosciences Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Calithera Biosciences Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Calithera Biosciences Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Calithera Biosciences Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Calithera Biosciences Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Calithera Biosciences Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Calithera Biosciences Inc disclose its waste policy?
Sign up for free to unlockDoes Calithera Biosciences Inc report according to TCFD requirements?
Sign up for free to unlockDoes Calithera Biosciences Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Calithera Biosciences Inc disclose energy use targets?
Sign up for free to unlockDoes Calithera Biosciences Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Calithera Biosciences Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Calithera Biosciences Inc
These potential risks are based on the size, segment and geographies of the company.
Calithera Biosciences, Inc., a clinical-stage bio-pharmaceutical company, focuses on the discovery and development of small molecule compounds for tumor metabolism and tumor immunology targets for the treatment of cancer in the United States. The company offers INCB001158, an orally bioavailable arginase inhibitor of arginase that is in Phase 1/2 clinical trial for the treatment of hematology and oncology. It is developing CB-280, an oral arginase inhibitor that has completed Phase 1b clinical trial for the treatment of cystic fibrosis and chronic airway infection; and ATG-037, an orally-bioavailable small molecule inhibitor of CD73, as well as CB-668, an orally administered inhibitor of the enzyme IL4I1. The company has a license agreement with Mars, Inc. to develop and commercialize Symbioscience's portfolio of arginase inhibitors for use in human healthcare. It also has clinical trial collaboration with Pfizer to evaluate Pfizer's PARP inhibitor talazoparib and CDK4/6 inhibitor palbociclib, each in combination with telaglenasta. In addition, the company has a collaboration and license agreement with Incyte Corporation for the research, development, and commercialization of INCB001158, a small molecule arginase inhibitor for the treatment of hematology and oncology; and a license agreement with Antengene Corporation Ltd. for the development and commercialization of CB-708. Calithera Biosciences, Inc. was incorporated in 2010 and is headquartered in South San Francisco, California.